212 related articles for article (PubMed ID: 16047414)
1. Klebsiella pneumoniae type 3 fimbria-mediated immunity to infection in the murine model of respiratory disease.
Lavender H; Jagnow JJ; Clegg S
Int J Med Microbiol; 2005 Jun; 295(3):153-9. PubMed ID: 16047414
[TBL] [Abstract][Full Text] [Related]
2. Targeting subcapsular antigens for prevention of Klebsiella pneumoniae infections.
Clements A; Jenney AW; Farn JL; Brown LE; Deliyannis G; Hartland EL; Pearse MJ; Maloney MB; Wesselingh SL; Wijburg OL; Strugnell RA
Vaccine; 2008 Oct; 26(44):5649-53. PubMed ID: 18725260
[TBL] [Abstract][Full Text] [Related]
3. Immunization with the outer membrane proteins OmpK17 and OmpK36 elicits protection against Klebsiella pneumoniae in the murine infection model.
Hussein KE; Bahey-El-Din M; Sheweita SA
Microb Pathog; 2018 Jun; 119():12-18. PubMed ID: 29626658
[TBL] [Abstract][Full Text] [Related]
4. Local immunity to klebsiella pneumoniae in the lungs of mice.
Cooper JM; Finlay-Jones JJ; Hill NL; Rowley D
J Infect Dis; 1983 Feb; 147(2):312-7. PubMed ID: 6338131
[TBL] [Abstract][Full Text] [Related]
5. Cyclic di-GMP stimulates protective innate immunity in bacterial pneumonia.
Karaolis DK; Newstead MW; Zeng X; Hyodo M; Hayakawa Y; Bhan U; Liang H; Standiford TJ
Infect Immun; 2007 Oct; 75(10):4942-50. PubMed ID: 17646358
[TBL] [Abstract][Full Text] [Related]
6. Intratracheal immunization with pili protein protects against mortality associated with Pseudomonas aeruginosa pneumonia in mice.
Ohama M; Hiramatsu K; Miyajima Y; Kishi K; Nasu M; Kadota J
FEMS Immunol Med Microbiol; 2006 Jun; 47(1):107-15. PubMed ID: 16706793
[TBL] [Abstract][Full Text] [Related]
7. Klebsiella pneumoniae MrkD adhesin-mediated immunity to respiratory infection and mapping the antigenic epitope by phage display library.
Li Y; Han WY; Li ZJ; Lei LC
Microb Pathog; 2009 Mar; 46(3):144-9. PubMed ID: 19100827
[TBL] [Abstract][Full Text] [Related]
8. Effects of ethanol on cytokine production after surgery in a murine model of gram-negative pneumonia.
Spies CD; Lanzke N; Schlichting U; Muehlbauer S; Pipolo C; von Mettenheim M; Lehmann A; Morawietz L; Nattermann H; Sander M
Alcohol Clin Exp Res; 2008 Feb; 32(2):331-8. PubMed ID: 18162079
[TBL] [Abstract][Full Text] [Related]
9. Immunoprotective potential of polysaccharide-tetanus toxoid conjugate in Klebsiella pneumoniae induced lobar pneumonia in rats.
Chhibber S; Rani M; Vanashree Y
Indian J Exp Biol; 2005 Jan; 43(1):40-5. PubMed ID: 15691064
[TBL] [Abstract][Full Text] [Related]
10. Role of plasmid-encoded antigens of Yersinia enterocolitica in humoral immunity against secondary Y. enterocolitica infection in mice.
Vogel U; Autenrieth IB; Berner R; Heesemann J
Microb Pathog; 1993 Jul; 15(1):23-36. PubMed ID: 8412625
[TBL] [Abstract][Full Text] [Related]
11. Klebsiella pneumoniae alleviates influenza-induced acute lung injury via limiting NK cell expansion.
Wang J; Li F; Sun R; Gao X; Wei H; Tian Z
J Immunol; 2014 Aug; 193(3):1133-41. PubMed ID: 24951819
[TBL] [Abstract][Full Text] [Related]
12. Induction of resistance to respiratory tract infection with Klebsiella pneumoniae in mice fed on a diet supplemented with tulsi (Ocimum sanctum) and clove (Syzgium aromaticum) oils.
Saini A; Sharma S; Chhibber S
J Microbiol Immunol Infect; 2009 Apr; 42(2):107-13. PubMed ID: 19597641
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of ethanol on IFN-gamma- and TNF-alpha-producing splenic T lymphocytes in a murine model of gram-negative pneumonia.
Lanzke N; Kleinwächter R; Kerschischnik S; Sargsyan L; Groneberg DA; Kamradt T; Liesenfeld O; Krenn V; Sander M; Spies C
Addict Biol; 2007 Mar; 12(1):59-68. PubMed ID: 17407498
[TBL] [Abstract][Full Text] [Related]
14. Preliminary investigation of a mice model of Klebsiella pneumoniae subsp. ozaenae induced pneumonia.
Renois F; Jacques J; Guillard T; Moret H; Pluot M; Andreoletti L; de Champs C
Microbes Infect; 2011 Nov; 13(12-13):1045-51. PubMed ID: 21723409
[TBL] [Abstract][Full Text] [Related]
15. Role of antibodies against outer-membrane proteins in murine resistance to infection with encapsulated Klebsiella pneumoniae.
Serushago BA; Mitsuyama M; Handa T; Koga T; Nomoto K
J Gen Microbiol; 1989 Aug; 135(8):2259-68. PubMed ID: 2699330
[TBL] [Abstract][Full Text] [Related]
16. Immunization against fatal experimental Klebsiella pneumoniae pneumonia.
Cryz SJ; Fürer E; Germanier R
Infect Immun; 1986 Nov; 54(2):403-7. PubMed ID: 3533779
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the host responses to wild-type and cpsB mutant Klebsiella pneumoniae infections.
Lawlor MS; Handley SA; Miller VL
Infect Immun; 2006 Sep; 74(9):5402-7. PubMed ID: 16926436
[TBL] [Abstract][Full Text] [Related]
18. Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection.
Skelding KA; Hickey DK; Horvat JC; Bao S; Roberts KG; Finnie JM; Hansbro PM; Beagley KW
Vaccine; 2006 Jan; 24(3):355-66. PubMed ID: 16153755
[TBL] [Abstract][Full Text] [Related]
19. IL-12 gene therapy protects mice in lethal Klebsiella pneumonia.
Greenberger MJ; Kunkel SL; Strieter RM; Lukacs NW; Bramson J; Gauldie J; Graham FL; Hitt M; Danforth JM; Standiford TJ
J Immunol; 1996 Oct; 157(7):3006-12. PubMed ID: 8816409
[TBL] [Abstract][Full Text] [Related]
20. Identification of Klebsiella pneumoniae virulence determinants using an intranasal infection model.
Lawlor MS; Hsu J; Rick PD; Miller VL
Mol Microbiol; 2005 Nov; 58(4):1054-73. PubMed ID: 16262790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
